List view / Grid view

Sanofi Pasteur

 

article

Building robust PCR/qPCR assays

26 April 2012 | By Linda Starr-Spires, Director, Nucleic Acid Methods Platform, Global Clinical Immunology Department, Sanofi Pasteur

The process of building robust PCR/qPCR assays is a matter of perseverance and consistency. A few questions that should be answered prior to starting development will help make the process more efficient and effective: Does the assay need to simply detect the presence of the target (qualitative), or must it…

news

Outsource to Europe

2 July 2010 | By NG Online News

The pharmaceutical industry has faced well documented challenges over the last 12 months, such as the Pfizer...